Craig-Hallum Keeps Their Buy Rating on Hut 8 Mining Corp (HUT)
Needham Adjusts Price Target on Blue Bird to $65 From $52, Maintains Buy Rating
Core Scientific Analyst Ratings
B. Riley Upgrades Core Scientific to Buy From Neutral, Adjusts Price Target to $13 From $0.50
Cantor Fitzgerald Initiates Core Scientific at Overweight With $20 Price Target
Blue Bird Analyst Ratings
Craig-Hallum Keeps Their Buy Rating on Aspen Aerogels (ASPN)
Mirum Pharmaceuticals (MIRM) Gets a Buy From JMP Securities
Craig-Hallum Reaffirms Their Buy Rating on Aspen Aerogels (ASPN)
Blue Bird (BLBD) Receives a Buy From Craig-Hallum
Core Scientific Analyst Ratings
Buy Rating Affirmed for Core Scientific Inc. on Debt Conversion and Expanded CoreWeave Contract
Core Scientific Analyst Ratings
Arlo Technologies Analyst Ratings
Craig-Hallum Sticks to Its Buy Rating for Arlo Technologies (ARLO)
Buy Rating Justified: Mirum Pharmaceuticals' Growth Prospects and Market Expansion Post-Livmarli Approval
Mirum Pharmaceuticals Analyst Ratings
Buy Rating Affirmed for Mirum Pharmaceuticals on LIVMARLI's EU Approval and Positive Revenue Projections
Core Scientific Analyst Ratings
Lake Street Remains a Buy on Arlo Technologies (ARLO)